Home > Income Statement > GENPHARMASEC

GENPHARMASEC
Revenue

    Back to Income Statement
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for GENPHARMASEC
Please provide your vote to see the results

GENPHARMASEC Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023
Net Sales ₹30 Cr₹26 Cr₹26 Cr

What is the latest Revenue of GENPHARMASEC ?

The latest Revenue ratio of GENPHARMASEC is ₹30 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹30 Cr
Mar2024₹26 Cr
Mar2023₹26 Cr

How is Revenue of GENPHARMASEC Trending?

Years Revenue % Change
Mar2025 ₹30 Cr
19.16
Mar2024 ₹26 Cr
0.00
Mar2023 ₹26 Cr -

Compare Revenue of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹86.9 Cr -11.8% -16% -46.7% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹9,125.4 Cr -1.8% -13.1% 14.8% Stock Analytics
KIRI INDUSTRIES ₹3,234.9 Cr -4.2% -10.4% 40.2% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹1,690.4 Cr 0.4% -6.8% -28.2% Stock Analytics
SHREE PUSHKAR CHEMICALS & FERTILISERS ₹1,273.9 Cr -7.5% -10% 54.9% Stock Analytics
BODAL CHEMICALS ₹768.3 Cr -1.5% -2.7% -18.8% Stock Analytics


GENPHARMASEC Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

-11.8%

-16%

-46.7%

SENSEX

-1.4%

3.1%

3.8%


You may also like the below Video Courses